Parkinson's Disease Trial, Not Yet Recruiting NCT05810454 Sponsor: iPACES LLC Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT05810454
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 50 years of age or older.
  • People who have been identified as having mild cognitive impairment (MCI — a level of memory or thinking difficulty that is more than normal aging but less than dementia), confirmed by study staff using a standard memory test with a score in a specific range.
  • People who are available to take part for one year, including completing tablet-based surveys and video call assessments.
  • People who are willing and able to exercise 3 to 5 times per week for at least 6 months.
  • People who are able to use a pedal device that sits under a table (similar to a small elliptical machine).
  • People who are able to read from a small tablet screen.
  • People who can speak and read English well enough to complete interviews, surveys, and an in-study game (a Spanish language option is expected to be available soon).
  • People who can take part in assessments and use a tablet touchscreen, including having adequate hearing, vision, and speech.
  • People who have written approval from their regular doctor, and from a heart specialist if they see one, to take part in exercise for this study.
  • People who are able to give informed consent to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are already exercising at recommended levels (45 minutes of moderate-intensity aerobic exercise, 5 to 7 times per week).
  • People with a significant history of heart or cardiovascular problems.
  • People with a significant history of stroke.
  • People with a significant history of serious memory problems, such as dementia or Alzheimer's disease.
  • People with a significant history of other neurological conditions, such as seizures.
  • People with significant uncontrolled tremor (shaking) that would interfere with using a touchscreen throughout the study.
  • People who are prone to cybersickness, such as motion sickness in cars or discomfort from screen use (confirm with trial site).
  • People who are unable to give informed consent, as assessed through a phone screening process.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bob Gillen, PhD, iPACES LLC

Phone: 737-747-2237

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
iPACES LLC
Registry
ClinicalTrials.gov
Start date
1 August 2023
Est. completion
1 August 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

executive function; everyday function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov